Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 233

1.

Successful treatment with canakinumab of a paediatric patient with resistant Behçet's disease.

Pagnini I, Bondi T, Simonini G, Giani T, Marino A, Cimaz R.

Rheumatology (Oxford). 2015 May 19. pii: kev197. [Epub ahead of print] No abstract available.

PMID:
25989957
2.

Complications of systemic juvenile idiopathic arthritis: risk factors and management recommendations.

Woerner A, von Scheven-Gête A, Cimaz R, Hofer M.

Expert Rev Clin Immunol. 2015 May;11(5):575-88. doi: 10.1586/1744666X.2015.1032257. Epub 2015 Apr 4.

PMID:
25843554
3.

Elicitation of expert prior opinion: application to the MYPAN trial in childhood polyarteritis nodosa.

Hampson LV, Whitehead J, Eleftheriou D, Tudur-Smith C, Jones R, Jayne D, Hickey H, Beresford MW, Bracaglia C, Caldas A, Cimaz R, Dehoorne J, Dolezalova P, Friswell M, Jelusic M, Marks SD, Martin N, McMahon AM, Peitz J, van Royen-Kerkhof A, Soylemezoglu O, Brogan PA.

PLoS One. 2015 Mar 30;10(3):e0120981. doi: 10.1371/journal.pone.0120981. eCollection 2015.

4.

Demethylation of the RORC2 and IL17A in human CD4+ T lymphocytes defines Th17 origin of nonclassic Th1 cells.

Mazzoni A, Santarlasci V, Maggi L, Capone M, Rossi MC, Querci V, De Palma R, Chang HD, Thiel A, Cimaz R, Liotta F, Cosmi L, Maggi E, Radbruch A, Romagnani S, Dong J, Annunziato F.

J Immunol. 2015 Apr 1;194(7):3116-26. doi: 10.4049/jimmunol.1401303. Epub 2015 Mar 4.

PMID:
25740946
5.

Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaboration.

Moorthy LN, Roy E, Kurra V, Peterson MG, Hassett AL, Lehman TJ, Scott C, El-Ghoneimy D, Saad S, El Feky R, Al-Mayouf S, Dolezalova P, Malcova H, Herlin T, Nielsen S, Wulffraat N, van Royen A, Marks SD, Belot A, Brunner J, Huemer C, Foeldvari I, Horneff G, Saurenman T, Schroeder S, Pratsidou-Gertsi P, Trachana M, Uziel Y, Aggarwal A, Constantin T, Cimaz R, Giani T, Cantarini L, Falcini F, Manzoni SM, Ravelli A, Rigante D, Zulian F, Miyamae T, Yokota S, Sato J, Magalhaes CS, Len CA, Appenzeller S, Knupp SO, Rodrigues MC, Sztajnbok F, de Almeida RG, de Jesus AA, de Arruda Campos LM, Silva C, Lazar C, Susic G, Avcin T, Cuttica R, Burgos-Vargas R, Faugier E, Anton J, Modesto C, Vazquez L, Barillas L, Barinstein L, Sterba G, Maldonado I, Ozen S, Kasapcopur O, Demirkaya E, Benseler S.

Pediatr Rheumatol Online J. 2014 Nov 25;12:49. doi: 10.1186/1546-0096-12-49. eCollection 2014.

6.

Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes.

Rosé CD, Pans S, Casteels I, Anton J, Bader-Meunier B, Brissaud P, Cimaz R, Espada G, Fernandez-Martin J, Hachulla E, Harjacek M, Khubchandani R, Mackensen F, Merino R, Naranjo A, Oliveira-Knupp S, Pajot C, Russo R, Thomée C, Vastert S, Wulffraat N, Arostegui JI, Foley KP, Bertin J, Wouters CH.

Rheumatology (Oxford). 2015 Jun;54(6):1008-16. doi: 10.1093/rheumatology/keu437. Epub 2014 Nov 20.

7.

Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin.

Pagnini I, Simonini G, Cavalli L, la Marca G, Iuliano A, Brandi ML, Bellisai F, Frediani B, Galeazzi M, Cantarini L, Cimaz R.

Pediatr Rheumatol Online J. 2014 Oct 23;12:47. doi: 10.1186/1546-0096-12-47. eCollection 2014.

8.

Safety considerations when prescribing immunosuppression medication to pregnant women.

Gerosa M, Meroni PL, Cimaz R.

Expert Opin Drug Saf. 2014 Dec;13(12):1591-9. doi: 10.1517/14740338.2014.951326. Epub 2014 Sep 5.

PMID:
25189270
9.

Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis.

Caso F, Costa L, Rigante D, Vitale A, Cimaz R, Lucherini OM, Sfriso P, Verrecchia E, Tognon S, Bascherini V, Galeazzi M, Punzi L, Cantarini L.

Autoimmun Rev. 2014 Dec;13(12):1220-9. doi: 10.1016/j.autrev.2014.08.010. Epub 2014 Aug 23. Review.

PMID:
25182201
10.

Biological treatments in Behçet's disease: beyond anti-TNF therapy.

Caso F, Costa L, Rigante D, Lucherini OM, Caso P, Bascherini V, Frediani B, Cimaz R, Marrani E, Nieves-Martín L, Atteno M, Raffaele CG, Tarantino G, Galeazzi M, Punzi L, Cantarini L.

Mediators Inflamm. 2014;2014:107421. doi: 10.1155/2014/107421. Epub 2014 Jun 30. Review.

11.

Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

Davì S, Minoia F, Pistorio A, Horne A, Consolaro A, Rosina S, Bovis F, Cimaz R, Gamir ML, Ilowite NT, Kone-Paut I, Feitosa de Oliveira SK, McCurdy D, Silva CA, Sztajnbok F, Tsitsami E, Unsal E, Weiss JE, Wulffraat N, Abinun M, Aggarwal A, Apaz MT, Astigarraga I, Corona F, Cuttica R, D'Angelo G, Eisenstein EM, Hashad S, Lepore L, Mulaosmanovic V, Nielsen S, Prahalad S, Rigante D, Stanevicha V, Sterba G, Susic G, Takei S, Trauzeddel R, Zletni M, Ruperto N, Martini A, Cron RQ, Ravelli A; Paediatric Rheumatology International Trials Organisation, the Childhood Arthritis and Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group, and the Histiocyte Society.

Arthritis Rheumatol. 2014 Oct;66(10):2871-80. doi: 10.1002/art.38769.

PMID:
25044674
12.

Glucocorticoid-associated osteoporosis in chronic inflammatory diseases: epidemiology, mechanisms, diagnosis, and treatment.

von Scheven E, Corbin KJ, Stagi S, Cimaz R.

Curr Osteoporos Rep. 2014 Sep;12(3):289-99. doi: 10.1007/s11914-014-0228-x. Review. Erratum in: Curr Osteoporos Rep. 2014 Sep;12(3):383. Stefano, Stagi [corrected to Stagi, Stefano].

PMID:
25001898
13.

The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy.

Cantarini L, Vitale A, Lucherini OM, De Clemente C, Caso F, Costa L, Emmi G, Silvestri E, Magnotti F, Maggio MC, Prinzi E, Lopalco G, Frediani B, Cimaz R, Galeazzi M, Rigante D.

Clin Rheumatol. 2015 Jan;34(1):17-28. doi: 10.1007/s10067-014-2721-0. Epub 2014 Jun 24.

PMID:
24953660
14.

Adalimumab in the treatment of immune-mediated diseases.

Lapadula G, Marchesoni A, Armuzzi A, Blandizzi C, Caporali R, Chimenti S, Cimaz R, Cimino L, Gionchetti P, Girolomoni G, Lionetti P, Marcellusi A, Mennini FS, Salvarani C.

Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):33-48. Review.

PMID:
24774505
15.

anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab.

Armuzzi A, Lionetti P, Blandizzi C, Caporali R, Chimenti S, Cimino L, Gionchetti P, Girolomoni G, Lapadula G, Marchesoni A, Marcellusi A, Mennini FS, Salvarani C, Cimaz R.

Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):11-32. Review.

PMID:
24774504
16.

The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases.

Blandizzi C, Gionchetti P, Armuzzi A, Caporali R, Chimenti S, Cimaz R, Cimino L, Lapadula G, Lionetti P, Marchesoni A, Marcellusi A, Mennini FS, Salvarani C, Girolomoni G.

Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):1-10. Review.

PMID:
24774503
17.

Current evidence of anti-tumor necrosis factor α treatment efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach of individual drugs.

Simonini G, Druce K, Cimaz R, Macfarlane GJ, Jones GT.

Arthritis Care Res (Hoboken). 2014 Jul;66(7):1073-84. doi: 10.1002/acr.22214. Review.

PMID:
24740981
18.

Does switching anti-TNFα biologic agents represent an effective option in childhood chronic uveitis: the evidence from a systematic review and meta-analysis approach.

Simonini G, Katie D, Cimaz R, Macfarlane GJ, Jones GT.

Semin Arthritis Rheum. 2014 Aug;44(1):39-46. doi: 10.1016/j.semarthrit.2014.03.001. Epub 2014 Mar 6. Review.

PMID:
24709278
19.

Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling.

Rice GI, del Toro Duany Y, Jenkinson EM, Forte GM, Anderson BH, Ariaudo G, Bader-Meunier B, Baildam EM, Battini R, Beresford MW, Casarano M, Chouchane M, Cimaz R, Collins AE, Cordeiro NJ, Dale RC, Davidson JE, De Waele L, Desguerre I, Faivre L, Fazzi E, Isidor B, Lagae L, Latchman AR, Lebon P, Li C, Livingston JH, Lourenço CM, Mancardi MM, Masurel-Paulet A, McInnes IB, Menezes MP, Mignot C, O'Sullivan J, Orcesi S, Picco PP, Riva E, Robinson RA, Rodriguez D, Salvatici E, Scott C, Szybowska M, Tolmie JL, Vanderver A, Vanhulle C, Vieira JP, Webb K, Whitney RN, Williams SG, Wolfe LA, Zuberi SM, Hur S, Crow YJ.

Nat Genet. 2014 May;46(5):503-9. doi: 10.1038/ng.2933. Epub 2014 Mar 30.

20.

Serum amyloid-A in Behçet's disease.

Vitale A, Rigante D, Lopalco G, Brizi MG, Caso F, Franceschini R, Denaro R, Galeazzi M, Punzi L, Iannone F, Lapadula G, Simpatico A, Marrani E, Costa L, Cimaz R, Cantarini L.

Clin Rheumatol. 2014 Aug;33(8):1165-7.

PMID:
24659331
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk